71. A population PK–PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808. (9th July 2022) Authors: Chung, Tae Kyu; Lee, Hyun A.; Lee, Kyeong‐Ryoon; Jang, Seong Bok; Yu, Kyung‐Sang; Lee, Howard Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 9(2022) Page Start: 1223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
72. A Prototype QSP Model of the Immune Response to SARS‐CoV‐2 for Community Development. (21st December 2020) Authors: Dai, Wei; Rao, Rohit; Sher, Anna; Tania, Nessy; Musante, Cynthia J.; Allen, Richard Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
73. A Prototype QSP Model of the Immune Response to SARS‐CoV‐2 for Community Development. (21st December 2020) Authors: Dai, Wei; Rao, Rohit; Sher, Anna; Tania, Nessy; Musante, Cynthia J.; Allen, Richard Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
74. A quantitative approach to the choice of number of samples for percentile estimation in bootstrap and visual predictive check analyses. (17th April 2022) Authors: Jonsson, E. Niclas; Nyberg, Joakim Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 6(2022) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
75. A Quantitative System Pharmacology Computer Model for Cognitive Deficits in Schizophrenia. (3rd April 2013) Authors: Geerts, H; Roberts, P; Spiros, A Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 4(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
76. A quantitative systems pharmacology approach to predict the safe‐equivalent dose of doxorubicin in patients with cardiovascular comorbidity. (13th October 2021) Authors: Sang, Lan; Yuan, Yi; Zhou, Ying; Zhou, Zhengying; Jiang, Muhan; Liu, Xiaoquan; Hao, Kun; He, Hua Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 12(2021) Page Start: 1512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
77. A quantitative systems pharmacology approach to support mRNA vaccine development and optimization. (21st October 2021) Authors: Selvaggio, Gianluca; Leonardelli, Lorena; Lofano, Giuseppe; Fresnay, Stephanie; Parolo, Silivia; Medini, Duccio; Siena, Emilio; Marchetti, Luca Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 12(2021) Page Start: 1448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
78. A quantitative systems pharmacology approach to support mRNA vaccine development and optimization. (21st October 2021) Authors: Selvaggio, Gianluca; Leonardelli, Lorena; Lofano, Giuseppe; Fresnay, Stephanie; Parolo, Silvia; Medini, Duccio; Siena, Emilio; Marchetti, Luca Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 12(2021) Page Start: 1448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
79. A Quantitative Systems Pharmacology Kidney Model of Diabetes Associated Renal Hyperfiltration and the Effects of SGLT Inhibitors. (22nd October 2018) Authors: Balazki, Pavel; Schaller, Stephan; Eissing, Thomas; Lehr, Thorsten Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 7:Number 12(2018) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
80. A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat. (19th June 2020) Authors: Abrams, Ruth; Kaddi, Chanchala D.; Tao, Mengdi; Leiser, Randolph J.; Simoni, Giulia; Reali, Federico; Tolsma, John; Jasper, Paul; van Rijn, Zachary; Li, Jing; Niesner, Bradley; Barrett, Jeffrey S.; Marchetti, Luca; Peterschmitt, M. Judith; Azer, Karim; Neves‐Zaph, Susana Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 7(2020) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗